AMAjay Mili

Ajay Mili

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ajay Mili has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Richard Lobo

    Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India

    5 shared publications
  • Krishnadas Nandakumar

    Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India

    3 shared publications
  • Krishnadas Nandakumar

    Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka-576104, India

    2 shared publications
  • Priyobrat Rajkhowa

    Health Policy, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka, 576104

    2 shared publications
  • Subham Das

    Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India

    2 shared publications
  • Anna Mathew

    Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India

    1 shared publication

Latest Publications

  • Open Access

    Investigating the Protective Role of Folic Acid in Fluoride‐Induced Neurotoxicity: An Integrative Computational and In Vivo Study

    by Newly Bagang, Ajay Mili, Aqsa Fathima, Nitesh Kumar, Somasish Ghosh Dastidar, Anoop Kishore, K. G. Mohandas Rao, G. Sivakumar, Smita Shenoy

    Background: Excessive fluoride exposure has been associated with neurotoxicity, including cognitive deficits and an increased risk of dementia. SIRT1, a key regulator of oxidative stress, apoptosis, and inflammation, is downregulated in fluoride‐induced neurotoxicity. This study aimed to identify a potential nutraceutical compound that modulates SIRT1 and explore its effects in a rat model of fluoride‐induced neurotoxicity. Methods: Comprehensive computational approaches, including molecular docking, ADMET predictions, and molecular simulations, were employed. Rats were exposed to 50 ppm sodium fluoride (NaF) alone or cotreated with folic acid (FA; 2.5 or 5 mg/kg) for 8 weeks. NaF was provided in drinking water, and FA was administered via oral gavage. Neurotoxicity was assessed using behavioral paradigms (Morris water maze, novel object recognition test), along with the evaluation of SIRT1 levels, oxidative stress markers, apoptosis, inflammatory cytokines, acetylcholinesterase, and hippocampal histopathology. Results: Computational screening identified FA as a potential SIRT1 modulator. NaF treatment reduced brain SIRT1 levels ( p < 0.05) and was accompanied by increased oxidative stress, apoptosis, and inflammation, leading to learning and memory deficits. FA cotreatment mitigated these alterations, improving behavioral performance, preserving hippocampal structure, and restoring key biochemical markers. FA increased SIRT1, SOD, and Bcl2 levels, while reducing MDA, caspase 3, TNF‐ α , IL‐6, and AChE levels. Conclusion: FA may exert protective effects against fluoride‐induced neurotoxicity, potentially through SIRT1 activation and the modulation of oxidative stress, apoptosis, and inflammation. However, further in‐depth studies are needed to better understand its precise protective mechanisms and evaluate its translational relevance, particularly the extent to which SIRT1 activation contributes to these effects.

  • Open Access

    Computational design, synthesis, in vitro and in vivo evaluation of a 3,4-methylenedioxyphenol (sesamol) derivative as an NRF2/HO-1 pathway activator for protection against drug-induced liver injury

    by Ajay Mili, Sumit Birangal, Krishnadas Nandakumar, Raghu Chandrashekar Hariharapura, Nitesh Kumar, Aravinda Pai, Richard Lobo

    A sesamol derivative (SMD) was designed as a potent NRF2/HO-1 activator showing enhanced hepatoprotection in vitro and in vivo .

  • Open Access

    NETWORK PHARMACOLOGY BASED COMPUTATIONAL STUDY TO INVESTIGATE THE POTENTIAL MECHANISM OF SYZYGIUM CARYOPHYLLATUM AGAINST COLON CANCER

    by Ramadevi Pemmereddy, Ajay Mili, Bharath Harohalli Byregowda, Jyothi Giridhar, Sreedhara Ranganath Pai K, Anna Mathew, Vasudev Pai, Chandrashekar K. S

    Objective: Syzygium caryophyllatum, a traditional medicinal plant from the Myrtaceae family, is rich in potential phytoconstituents. Based on its ethnobotanical uses and documented pharmacological activities, present work was conducted to evaluate the probable mechanism of action of S. caryophyllatum to manage colon cancer by integrating network pharmacology and computational studies. Methods: The plant extract was prepared by Soxhlet extraction method and in vitro screening was performed using Sulforhodamine (SRB) Assay on HT 29 cancer cell lines. We have used super-PRED database, Cytoscape network analyser tool, string database and CytoHubba for performing network analysis for the extract compounds reported in GC-MS analysis. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and DAVID databases were used for gene set enrichment analysis. We have used Schrödinger suite Version 11.4's to perform computational studies. Results: The extract has demonstrated significant in vitro cytotoxic activity (IC50 value is 49.01 µg/ml) and the GC-MS analysis identified seventy-six distinct compounds. The Gene Ontology (GO) and KEGG demonstrated that the shared targets were strongly associated with key processes involved in colon cancer. The current study has identified Estrogen Receptor Alpha (ESR1), Heat Shock Protein 90 Alpha Family Class A Member 1 (HSP90AA1), Mitogen-activated protein kinase 3 (MAP3K), Epidermal Growth Factor Receptor (EGFR) and Signal transducer and activator of transcription 3 (STAT3) proteins as essential targets and 5,7-Dihydroxy-2-undecyl-4H-chromen-4-one, 7a,12-Dihydroindolo[2,3-a] quinolizine, 5-hydroxy-7-methoxy-2-methyl-8-(3-methylbutyl) chromen-4-one as key compounds. Docking studies of the compounds with core proteins completely supplemented their binding affinity and suggested strong interactions at the binding site. Conclusion: These outcomes highlight the multi-target, multi-compound, and multi-pathway approaches of S. caryophyllatum against colon cancer.

  • Open Access

    Identifying the role of Phytomolecules in the management of liver diseases by modulating NRF2 pathway: A Scoping Review Protocol

    by Ajay Mili, Priyobrat Rajkhowa, Krishnadas Nandakumar, Richard Lobo

    Background The Liver is a vital organ in the human body, which plays a crucial role in various physiological processes. Oxidative stress is a critical factor in the pathogenesis and progression of various liver diseases, contributing to cellular damage and dysfunction. The Liver is particularly vulnerable to the harmful effects of reactive oxygen species when the balance between their production and the body’s antioxidant defense mechanisms is disrupted. The nuclear factor erythroid 2-related factor 2 (NRF2) pathway has emerged as a promising therapeutic target for liver diseases due to its pivotal role in cellular defense against oxidative stress and inflammation. Plants have always been a source of drugs which has been used to treat various pharmacological disorders and most of its activity is due to its potential as an antioxidant. However, the specific mechanisms by which they interact with the NRF2 pathway and confer protection against liver diseases remain inadequately elucidated. Therefore, this scoping review aims to identify and analyze the existing literature pertaining to the relationship between Phytomolecules, which can modulate NRF2 and protect against liver diseases. Methods The proposed scoping review will follow the steps given by “Arksey and O’Malley and Levac et al”. Electronic databases (PubMed/MEDLINE, Embase, etc.) will be searched for recent relevant studies. A predefined criterion for the inclusion and exclusion of studies will be independently adopted by two reviewers. The review will be presented as per the “Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Review (PRISMA-ScR)” guidelines. Conclusion The scoping review finding is expected to help understanding the role of Phytomolecules in preventing liver diseases by modulating the NRF2 pathway. Ultimately, this review will serve as a foundational step toward developing targeted interventions to improve liver health outcomes and reduce the global burden of liver diseases.

  • Open Access

    Identifying the role of Phytomolecules in the management of liver diseases by modulating NRF2 pathway: A Scoping Review Protocol

    by Ajay Mili, Priyobrat Rajkhowa, Krishnadas Nandakumar, Richard Lobo

    Background The Liver is a vital organ in the human body, which plays a crucial role in various physiological processes. Oxidative stress is a critical factor in the pathogenesis and progression of various liver diseases, contributing to cellular damage and dysfunction. The Liver is particularly vulnerable to the harmful effects of reactive oxygen species when the balance between their production and the body’s antioxidant defense mechanisms is disrupted. The nuclear factor erythroid 2-related factor 2 (NRF2) pathway has emerged as a promising therapeutic target for liver diseases due to its pivotal role in cellular defense against oxidative stress and inflammation. Plants have always been a source of drugs which has been used to treat various pharmacological disorders and most of its activity is due to its potential as an antioxidant. However, the specific mechanisms by which they interact with the NRF2 pathway and confer protection against liver diseases remain inadequately elucidated. Therefore, this scoping review aims to identify and analyze the existing literature pertaining to the relationship between Phytomolecules, which can modulate NRF2 and protect against liver diseases. Methods The proposed scoping review will follow the steps given by “Arksey and O’Malley and Levac et al”. Electronic databases (PubMed/MEDLINE, Embase, etc.) will be searched for recent relevant studies. A predefined criterion for the inclusion and exclusion of studies will be independently adopted by two reviewers. The review will be presented as per the “Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Review (PRISMA-ScR)” guidelines. Conclusion The scoping review finding is expected to help understanding the role of Phytomolecules in preventing liver diseases by modulating the NRF2 pathway. Ultimately, this review will serve as a foundational step toward developing targeted interventions to improve liver health outcomes and reduce the global burden of liver diseases.

  • Molecular docking and dynamics guided approach to identify potential anti-inflammatory molecules as NRF2 activator to protect against drug-induced liver injury (DILI): a computational study

    by Ajay Mili, Subham Das, Krishnadas Nandakumar, Richard Lobo

    Inflammation and oxidative stress can contribute to the etiology of metabolic and chronic illnesses. The ability to prevent oxidative stress induced diseases such as cancer, cardiovascular disease, Alzheimer’s disease, and others has been the subject of global research. Drug-induced liver injury (DILI) pathogenesis can be either due to oxidative stress or inflammatory response elicited by the drug, its metabolite, or herbal supplements. Our present research uses computational studies to identify a molecule with anti-inflammatory properties that can operate as an NRF2 activator. Acquiring and preparing the KEAP1-NRF2 Protein (PDB: 4L7D) with Schrodinger Suite was followed by developing a ligand library (Anti-inflammatory library downloaded from ChemDiv database). Molecular docking studies were performed in HTVS, SP, and XP modes, respectively. Based on the docking score, interaction, ADMET and binding free energy, the top ten compounds were selected and subjected to induced-fit docking (IFD) analysis for further study. The top three molecules were chosen for a molecular dynamics (MD) simulation study. Using the Desmond module of the Schrodinger Suite, the stability of the protein-ligand complex and protein-ligand contact throughout 100ns were evaluated during the MD simulation study. In our study, it was observed that three compounds exhibit exceptional stability and retain the essential interaction throughout the studies, and it is anticipated that these compounds may act as effective NRF2 activators. Further in vitro and in vivo assessments can be conducted to determine its potential to prevent DILI via acting as an NRF2 activator for future drug development. Communicated by Ramaswamy H. Sarma